Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 139.50 |
---|---|
High | 141.50 |
Low | 138.60 |
Bid | 139.40 |
Offer | 140.00 |
Previous close | 140.40 |
Average volume | 56.60 |
---|---|
Shares outstanding | 66.39m |
Free float | 66.01m |
P/E (TTM) | 32.76 |
Market cap | 10.35bn USD |
EPS (TTM) | 4.76 USD |
Annual div (ADY) | 1.66 EUR |
---|---|
Annual div yield (ADY) | 1.20% |
Div ex-date | Jul 25 2024 |
Div pay-date | Aug 15 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
- Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
- Daniel Ackerman Named Aptar’s Chief Accounting Officer
- Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
- Aptar Reports Second Quarter 2024 Results
- Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
- Aptar Named One of the World’s Most Sustainable Companies 2024 by TIME
More ▼